- Specialization
- Not classified
- Business
Software Applicationsand 1 more business valuesLess
- Professional Services
- Market
- Life Sciences
- Ecosystem
- Applications
- Customers
- Enterprises
More details
- Organization type
- Commercial Company
- Ecosystem
- Applications
- Business
- Software Applications, Professional Services
- Specialization
- Not classified
- Market
- Life Sciences
- Customers
- Enterprises
- Delivery models
- Hosted Software, Professional Services
- Revenue models
- Services Fees
- Listing status
- Not classified
- Latest equity round
- Pre Seed
- Reported funding amount
- Not classified
About
Harbor builds compliant clinical-trial software centered on an electronic data capture system that automates eCRF, source-document, and study-data workflows for biotech, medtech, and other clinical teams. It differentiates itself by combining AI-enabled automation with regulated, full-service trial execution intended to reduce handoffs, accelerate studies, and improve margins versus legacy CROs.
Market
Harbor competes in the clinical-trial eClinical software, EDC/clinical-data-management, and CRO-services markets, addressing an $82 billion CRO market and a multi-billion-dollar EDC segment. Its positioning is an AI-native alternative to legacy EDC vendors and labor-intensive CROs: it uses protocol understanding, document extraction, automated data capture, monitoring, and an owned system of record to deliver faster study setup, fewer handoffs, lower operational cost, and audit-ready data.
Harbor primarily targets regulated pharmaceutical, biotech, and medical-device companies—especially lean teams and sponsors that want to run studies themselves or reduce reliance on expensive CRO and legacy EDC workflows. Its broader customer base includes CROs and large sponsors managing multiple active trials, as well as academic and investigator-initiated research programs; likely buyers are clinical-operations and clinical-data-management teams.
At a Glance
Problem
Harbor addresses the slow, expensive, and highly manual data-management layer of clinical trials. Legacy electronic data-capture systems can require two to three months of configuration before a study begins; clinical sites then spend hours transcribing patient information from EHRs or paper into the EDC, while sponsors employ large monitoring teams to travel to sites and verify the entries. The result is delayed data access, avoidable errors, slower database lock and regulatory submissions, and significant service expense.
The killer use case is study startup and ongoing source-data capture: turning a trial protocol into a compliant EDC quickly, then moving source documents into the study database without manual transcription. Harbor cites a customer case in which a fully validated EDC was delivered in nine days instead of a typical 10-to-12-week timeline, at a fraction of the cost.
Product / Service
Harbor began as an AI-native electronic data-capture system and is expanding into a full-service, AI-native contract research organization. Its Magic Build tool converts protocols into customized EDC databases, Magic Capture extracts data from electronic or paper source documents, and the platform automates workflows such as query generation, monitoring, signing, source-data verification, and database lock. Sponsors receive near-real-time access to cleaner data while sites reduce transcription work and monitors can perform more remote oversight.
The product is designed for regulated use rather than as a generic AI layer: Harbor describes validated environments with 21 CFR Part 11 and GCP compliance, immutable audit trails, electronic signatures, and role-based access controls. Academic and nonprofit users can use the platform free, while commercial studies start at $2,000 per month and larger sponsors or CROs receive volume-based offerings. In its newer service model, Harbor combines its own system of record with project management, monitoring, data management, site coordination, and other trial-execution services.
Market
Harbor competes in electronic data capture and broader eClinical data management, while its expansion places it in the contract research organization market. Direct software alternatives include Viedoc, REDCap, Medrio EDC, Clinical Research Suite, and cubeCDMS; Medidata Rave is a major incumbent EDC competitor. Harbor’s differentiation is an AI-first workflow that compresses configuration, data entry, and monitoring work while preserving the compliance controls required for regulatory submissions.
Harbor is not pre-revenue. Its public YC materials report seven supported trials and $15.6k in monthly software revenue, equivalent to roughly $187k in contracted software revenue over the following twelve months, and later report a first seven-figure contract to run a clinical trial end-to-end for a publicly traded medical-device company. The company was founded in 2025 and participated in YC’s Spring 2026 batch, so it remains an early-stage entrant challenging established EDC vendors and large CROs rather than a scaled incumbent.
Founders & Leadership
Funding History
Y Combinator
Recent News
Clinical Research Learning Network (CRLN) and Harbor announced the launch of hands-on electronic data capture (EDC) practice for aspiring clinical research professionals. The announcement describes a joint initiative intended to provide practical EDC experience.
Harbor introduced itself as a new system of record for data collection in clinical trials, positioning the product as an alternative to slow, labor-intensive legacy processes.
Active Roles
0No active roles right now.
Get notified when they postBusiness Model
Harbor generates software revenue from its clinical-trial platform and also sells full-service CRO services, including end-to-end trial execution. Its disclosed traction included $15.6k in monthly software revenue and a first seven-figure contract to run a clinical trial.